4798F752-AF91-9AEB-6B6F-A7991F0A4118.7D5FBFDE-C38F-F3AF-BA21-A79A6112EB58	4798F752-AF91-9AEB-6B6F-A7991F0A4118.441BBB0F-1F8F-C77C-E873-A79A792435BA	4798F752-AF91-9AEB-6B6F-A7991F0A4118.2FD9E45A-20C6-30B6-3B00-A79A99757381	5166A57D-101F-48AB-321A-A797F76284A8	A77BF592-E275-8533-E238-A797F762B7A1	EDFFC9F0-A6BF-EF7B-EEC9-A797F7624FA0	F1FE5266-8D9D-C0FA-7CE2-A797F7628908	A24C61FA-6D7A-769F-0CAB-A797F762D50Fmodified-cell-type: cell-type	modified-cell-type: gene	modified-cell-type: modification	promoter-construct	reagent	blocking-peptide	primary-antibody	protein-concentrationfibroblast	eps8	-/-	Eps8-myc	control	control	 Sos-1	7/7: very highfibroblast	eps8	-/-	control	control	control	 Sos-1	7/7: very highfibroblast	eps8	-/-	Eps8-myc	GST	control	Sos-1	0/7: nonefibroblast	eps8	-/-	Eps8-myc	Cdc42	control	Sos-1	0/7: nonefibroblast	eps8	-/-	Eps8-myc	Rac (GTP-Rac depleted of GTP)	control	Sos-1	6/7: highfibroblast	eps8	-/-	Eps8-myc	Rac (GTP-Rac depleted of GTP)	PPPPPVDYTEDEE (PXXDY)	Sos-1	1/7: very lowfibroblast	eps8	-/-	Eps8-myc	Rac (GTP-Rac depleted of GTP)	PPPPPPVDATEDEE (PXXDA)	Sos-1	6/7: highfibroblast	eps8	-/-	Eps8-myc	Rac (GTP-Rac depleted of GTP)	VPVPPPVPPRRR (PXXP)	Sos-1	1/7: very low